Bausch Health Companies Investor Conference Presentation Deck
17
Reconciliation of Solta Medical Net Income to EBITDA (non-
GAAP)¹ and Adjusted EBITDA (non-GAAP)¹ ($M)²
Net income attributable to Solta Medical
Provision for Income Taxes ³
Depreciation and amortization
EBITDA
Adjustments:
Asset impairments, including loss on assets held for sale
Acquisition-related costs and adjustments (excluding
amortization of intangible assets)
Share-based compensation
Adjusted EBITDA (non-GAAP)¹
BAUSCH Health
Twelve Months Ended
December 31,
2020
$
93
20
21
134
Twelve Months Ended
December 31,
2019
1
135 $
1. See Slide 2 and this Appendix for further non-GAAP information.
2. Excludes BHC corporate allocations and any potential standalone costs
3. Estimates which are subject to change
52
9
21
82
4
1
87
Twelve Months Ended
December 31,
2018
$
22
4
22
48
(1)
1
48
Twelve Months Ended
December 31,
2017
$
1
19
20
(1)
1
20View entire presentation